findmyKOL

Peter Hunt, MD

Enriched profile

Professor of Medicine (Professor in Residence); Interim Chief, Division of Experimental Medicine, UCSF · University of California, San Francisco

ORCIDNPI
Region🇺🇸 San Francisco, CA · West · United StatesSpecialtyInfectious DiseaseFocusHIV Research and Treatment+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH funding2005–2026Why? →

Peter Hunt is Professor of Medicine (Professor in Residence); Interim Chief, Division of Experimental Medicine, UCSF at University of California, San Francisco. OpenAlex indexes 465 publications with 27,839 citations (h-index 84); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory. Clarivate lists Peter Hunt as a Highly Cited Researcher (Cross-Field, 2018-2024).

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Peter Hunt, MD, is Professor of Medicine (Professor in Residence) at University of California, San Francisco. The public record shows 465 publications with 27,839 citations (h-index 84), centered on HIV Research and Treatment, HIV-related health complications and treatments, HIV/AIDS Research and Interventions. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 19 NIH-funded awards (2005–2026).

  • Top research focus: HIV Research and Treatment
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV3 trialsHIV Infections2 trialsVirus Diseases1 trialCytomegalovirus Infections1 trial

Research focus

OpenAlex concept fingerprint
HIV Research and TreatmentHIV-related health complications and treatmentsHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentImmune Cell Function and Interaction

Drugs & molecules

across trials, industry payments and publications
Delstrigogeneric · Doravirine / lamivudine / tenofovir disoproxilClinical trialsIndustry payments1PublicationsDificidgeneric · FidaxomicinClinical trialsIndustry payments1PublicationsIsentressgeneric · RaltegravirClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trialsIndustry payments32ViiV Healthcare CompanyClinical trialsIndustry payments7University of California, San FranciscoClinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
465publications

Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.

27,839citations

Total citations across indexed works.

84h-index

Hirsch index (OpenAlex). i10-index 275.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
19NIH grants · 2005–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    40.7%
    Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor16.7%
    Pifeltro100%
    Part D<11 patients
    Azole Antifungal12%
    Fluconazole100%
    Part D<11 patients
  • Nervous system

    35.2%
    Benzodiazepine13%
    Lorazepam100%
    Part D<11 patients
    Aminoketone12%
    Bupropion Hcl Sr100%
    Part D<11 patients
  • Cardiovascular

    24.1%
    Statin12%
    Rosuvastatin Calcium100%
    Part D<11 patients
    Calcium channel blocker12%
    Amlodipine Besylate-Benazepril100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

19 NIH research awards on record, funded 20052026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

2 congress contributions (2010–2023) across ASCO, ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/peter-hunt-md-8282a977

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com
  • ResearchGate

    researchgate.net/scientific-contributions/Peter-W-Hunt-39882008

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    croiconference.org/dt_team/peter-hunt-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiconference.org
  • Other

    croiwebcasts.org/console/player/50101

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiwebcasts.org
  • Other

    healio.com/infectious-disease/hiv-aids/news/online/%7B541a57e5-1c95-4fa2-8582-0230dbcf7ec1%7D/video-peter-hunt-md-reviews-comorbidities-inflammation-in-hiv

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Infectious Diseases, UCSF

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.ucsf.edu
  • Fellowship

    General Internal Medicine, UCSF

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.ucsf.edu
  • Residency

    Internal Medicine, UCSF

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.ucsf.edu
  • M.D.

    Yale University School of Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • B.A. in Biology

    Yale University

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • B.A.

    Biology, Yale University

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.ucsf.edu

Editorial & leadership roles

journal and society appointments
  • Vice Chair

    CROI (Conference on Retroviruses and Opportunistic Infections) 2026 Scientific Program Committee

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idse.net
  • Co-Director

    UCSF-GIVI Center for AIDS Research (Basic/Translational Sciences)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experimentalmedicine.ucsf.edu
  • Associate Chief for Research

    ZSFG-UCSF Department of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.ucsf.edu
7 more roles behind the reveal.Reveal →

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Cross-Field
    2018201920202021202220232024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
2 more affiliations behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
  • Guest

    "Going anti-Viral" podcast (IAS-USA), Episode 71: "CROI 2026 Review: What's New, What's Next in HIV Research"

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiconference.org
  • Guest

    "Going anti-Viral" podcast (IAS-USA), Episode 71: "CROI 2026 Review: What's New, What's Next in HIV Research"

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idse.net

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.